Eddie joined Catamaran as Senior Director, Intellectual Property in March 2021. Over his career, Eddie has represented a variety of companies and academic institutions in intellectual property matters, with a focus on biotechnology, including cell therapies, immunotherapeutics, gene editing therapeutics, and drug delivery devices. Prior to Catamaran, Eddie was intellectual property counsel for Rubius Therapeutics where he led the development and execution of patent strategies for the company’s cell therapy programs. Earlier in his career, Eddie was a member of the intellectual property practice groups of the law firms Fish and Richardson, McCarter & English, and Sterne, Kessler, Goldstein and Fox. Eddie holds a JD from the Boston University School of Law, a PhD in Microbiology from the University of Virginia, and a BS in Biology from the University of Puerto Rico-Rio Piedras.